Stonepine Capital Management, LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 7:47 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 0 0.000% |
-3,408,849 (Position Closed) |
Filing |
| 2021-03-01 6:06 pm Purchase |
2021-02-25 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 3,408,849 7.600% |
2,600,418 (+321.66%) |
Filing |
| 2021-02-12 4:48 pm Sale |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 808,431 2.800% |
-1,432,808 (-63.93%) |
Filing |